You are now leaving helsinn.com

Please click 'Continue to external site' if you want to continue.

Sergio Cantoreggi

Group Chief Scientific Officer, Global Head of R&D

Biography

  • Joined Helsinn as a Drug Development Scientist in 2000; appointed Head of R&D in 2004 and Chief Scientific Officer in 2011
  • Previously worked as a Toxicologist at Sandoz and Novartis
  • Holds a Masters in Chemistry and a PhD in Toxicology from the Federal Institute of Technology in Zürich and two post-doctoral fellowships carried out in Switzerland and in the U.S.

Helsinn’s Senior Executive Committee Team

Riccardo Braglia

Executive Chairman

Giorgio Calderari

Group CEO & Board Member

Matteo Missaglia

Group General Counsel, Group Chief Legal Officer

Konrad Wilson

Group Chief Financial Officer

Sergio Cantoreggi

Group Chief Scientific Officer, Global Head of R&D